Accuray (ARAY) Share-based Compensation Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Accuray | 47,295.88 | -38.49 Mn | 25.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -11.14% |
| Dec 31, 2025 | -17.91% |
| Sep 30, 2025 | 2.31% |
| Mar 31, 2025 | 6.37% |
| Dec 31, 2024 | 1.23% |
| Sep 30, 2024 | 6.72% |
| Mar 31, 2024 | -1.03% |
| Dec 31, 2023 | 6.52% |
| Sep 30, 2023 | -5.72% |
| Mar 31, 2023 | -13.42% |
| Dec 31, 2022 | -1.88% |
| Sep 30, 2022 | 3.70% |
| Mar 31, 2022 | -5.58% |
| Dec 31, 2021 | -1.56% |
| Sep 30, 2021 | -6.24% |
| Mar 31, 2021 | -6.94% |
| Dec 31, 2020 | -6.82% |
| Sep 30, 2020 | -2.25% |
| Jun 30, 2020 | -7.76% |
| Mar 31, 2020 | -9.80% |
| Dec 31, 2019 | -11.03% |
| Sep 30, 2019 | -12.28% |
| Jun 30, 2019 | 19.20% |
| Mar 31, 2019 | -2.45% |
| Dec 31, 2018 | -9.66% |
| Sep 30, 2018 | 8.06% |
| Jun 30, 2018 | 8.92% |
| Mar 31, 2018 | 9.15% |
| Dec 31, 2017 | 8.41% |
| Sep 30, 2017 | 6.74% |
| Jun 30, 2017 | 11.06% |
| Mar 31, 2017 | 15.57% |
| Dec 31, 2016 | 8.40% |
| Sep 30, 2016 | 5.89% |
| Jun 30, 2016 | -14.46% |
| Mar 31, 2016 | 12.91% |
| Dec 31, 2015 | 11.47% |
| Sep 30, 2015 | 0.14% |